VKH
LABD icon

Virtu KCG Holdings’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Virtu KCG Holdings’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$328K Buy
24
+18
+300% +$346K 0.01% 1573
2017
Q1 		$127K Sell
6
-28
-82% -$692K ﹤0.01% 2605
2016
Q4 		$1.29M Buy
34
+24
+240% +$923K 0.03% 569
2016
Q3 		$335K Buy
+10
New +$468K 0.01% 1813

Other funds holding LABD

Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CT
CMT Trading Chicago, Illinois $22.4M AUM 78.15% 1-Year Est. Return

Virtu KCG Holdings's LABD Position: Q2 2017 in Review

Virtu KCG Holdings increased its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 300% in Q2 2017, buying an estimated $346K and bringing the position to 24 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #1573.

Virtu KCG Holdings first reported a position in LABD in Q3 2016 and has held it in 4 quarters since. The position peaked at $1.29M in Q4 2016. 18 funds tracked by Wall St. Rank hold LABD as of Q2 2017.

  • Virtu KCG Holdings held 24 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $328K as of Q2 2017.
  • Virtu KCG Holdings bought 18 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2017, an estimated $346K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1573 holding.
  • Virtu KCG Holdings first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2016 and has held it in 4 quarters since.
  • Virtu KCG Holdings's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $1.29M in Q4 2016.
  • 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.